Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloid beta-peptide: the inside story.

Bertrand P Tseng1, Masashi Kitazawa, Frank M LaFerla

  • 1Laboratory of Molecular Neuropathogenesis, Department of Neurobiology and Behavior, University of California, Irvine, CA 92697-4545, USA.

Current Alzheimer Research
|June 25, 2005
PubMed
Summary

Amyloid beta-peptide (Abeta) accumulation inside neurons is increasingly recognized as a key factor in Alzheimer's disease (AD) and Down syndrome. This review explores evidence for intracellular Abeta's role in neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visceral adipose tissue differentially affects tau and Aβ pathology in 3xTg-AD mice.

Cell communication and signaling : CCS·2026
Same author

The TREM2 R47H variant is associated with liver-plasma-brain axis dyshomeostasis in the 5xFAD mouse model of Alzheimer's disease.

Neurobiology of aging·2026
Same author

Abi3<sup>S212F</sup> Alzheimer's disease variant alters plaque structure and disrupts microglia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Amyloid beta-peptide (Abeta) is implicated in Alzheimer's disease (AD) pathogenesis.
  • Abeta is traditionally found in extracellular plaques in AD and Down syndrome brains.
  • Intracellular Abeta accumulation is emerging as a significant contributor to neurodegenerative processes.

Purpose of the Study:

  • To review current evidence supporting a pathogenic role for intracellular Abeta.
  • To explore the contribution of intraneuronal Abeta to neurodegeneration in AD and Down syndrome.
  • To examine the relevance of intracellular Abeta in inclusion body myositis (IBM).

Main Methods:

  • Literature review of recent studies on intracellular Abeta.
  • Analysis of evidence linking intracellular Abeta to neuronal and synaptic dysfunction.

Related Experiment Videos

  • Comparative examination of Abeta's role in CNS disorders and IBM.

    • Main Results:

    • Growing evidence suggests intraneuronal Abeta contributes to neurodegenerative events.
    • Intracellular Abeta is a known component of inclusion body myositis (IBM).
    • Intracellular Abeta may induce cytopathic effects, leading to neuronal dysfunction and loss.

    Conclusions:

    • Intracellular Abeta is a plausible contributor to neurodegeneration in the central nervous system (CNS).
    • The role of intracellular Abeta in AD, Down syndrome, and IBM warrants further investigation.
    • Targeting intracellular Abeta may offer new therapeutic strategies for neurodegenerative diseases.